Clinical trial
A Study of AGN-195263 for the Treatment of Meibomian Gland Dysfunction
NCT01633788 is registered in ClinicalTrials.gov with Allergan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study of AGN-195263 for the Treatment of Meibomian Gland Dysfunction
- Lead sponsor
- Allergan
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- August 22, 2012
- Completion date
- February 5, 2015
- Enrollment
- 232 (actual)
- Sites
- 33
Conditions
As the registry lists them; a condition with its own page is linked.